Bogdanow Drives Children’s Motrin case

041715samanthaReckisMassachusetts’ highest court recently upheld a $63 million judgment against Johnson & Johnson in the case of then-7-year-old Samantha Reckis, who developed toxic epidermal necrolysis and nearly died after receiving multiple doses of Children’s Motrin. IB member Michael Bogdanow, partner at Meehan, Boyle, Black & Bogdanow, P.C., represented the family.

1959266_1Epidermal necrolysis, is a rare, life-threatening skin disorder that took 95% of the top layer of Samantha’s skin. She also suffered a stroke, blindness, cranial hemorrhage, loss of 80% of her lung capacity, seizures, along with liver and heart failure.

“This [ruling] doesn’t open the floodgates to frivolous lawsuits,” said Bogdanow. Samantha, now 18, is still “in and out of the hospital.”

The company had argued that had it given a more detailed warning, the Food and Drug Administration would not have approved it. But Patrick Jones, a Boston plaintiff’s lawyer specializing in product liability, disagreed, calling the court’s ruling a victory not only for the family, but for states’ rights, as well.

For more information on the case or Bogdanow, please visit

Tags: , , , , , , , , , , , , , ,

Comments are closed.